Profile picture

Mr Alexandru-Ioan Draghici

Cluj-Napoca (Romania)
Follow
Logo ESC

Contributor content

Serious adverse events, hospitalization, and mortality associated with icosapent ethyl: a pharmacovigilance analysis using the FDA adverse event reporting system
Presentation
Serious adverse events, hospitalization, and mortality associated with icosapent ethyl: a pharmacovigilance analysis using the FDA adverse event reporting system
See more
Diverging trends in premature cardiovascular mortality across europe: implications for the evolving heart failure burden
Presentation
Diverging trends in premature cardiovascular mortality across europe: implications for the evolving heart failure burden
See more
Comparative cardiac safety profiling of ALK inhibitors: an eudravigilance disproportionality analysis
Presentation
Comparative cardiac safety profiling of ALK inhibitors: an eudravigilance disproportionality analysis
See more
Comparative effectiveness of impella and IABP as ventricular unloading strategies in patients with cardiogenic shock undergoing ECMO: a systematic review and meta analysis
Presentation
Comparative effectiveness of impella and IABP as ventricular unloading strategies in patients with cardiogenic shock undergoing ECMO: a systematic review and meta analysis
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources